EUPRAXIA PHARMACEUTICALS INC. - EPRX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | SCHEDULE 13G/A | MANCHESTER MANAGEMENT COMPANY, LLC | 4.3% | 2,634,048 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | MANCHESTER MANAGEMENT PR, LLC | 4.3% | 2,634,048 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | MANCHESTER EXPLORER, L.P. | 4.1% | 2,511,121 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | JAMES E. BESSER | 4.5% | 2,772,341 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | MORGAN C. FRANK | 4.3% | 2,664,780 | View |
| May 12, 2026 | SCHEDULE 13G/A | Manchester Management Company, LLC | 7.4% | 3,830,869 | View |
| May 12, 2026 | SCHEDULE 13G/A | Manchester Management PR, LLC | 7.4% | 3,830,869 | View |
| May 12, 2026 | SCHEDULE 13G/A | Manchester Explorer, L.P. | 7.1% | 3,707,942 | View |
| May 12, 2026 | SCHEDULE 13G/A | James E. Besser | 7.6% | 3,969,162 | View |
| May 12, 2026 | SCHEDULE 13G/A | Morgan C. Frank | 7.7% | 4,015,248 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.